Continuous sibutramine (CS), intermittent sibutramine (IS), or placebo for obesityâ€
| Outcomes at 44 weeks | Comparisons | Event rates | RBI (95% CI) | NNT (CI) |
|---|---|---|---|---|
| †Abbreviations defined in glossary; RBI, NNT, and CI calculated from data in article. | ||||
| 5% weight loss | CS v placebo | 65% v 35% | 86% (54 to 130) | 4 (3 to 5) |
| IS v placebo | 63% v 35% | 81% (49 to 123) | 4 (3 to 6) | |
| 10% weight loss | CS v placebo | 32% v 13% | 148% (71 to 266) | 6 (4 to 9) |
| IS v placebo | 33% v 13% | 154% (75 to 276) | 6 (4 to 8) | |